These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9365878)

  • 1. Predictors of renal and cardiovascular mortality in patients with non-insulin-dependent diabetes: a brief overview of microalbuminuria and insulin resistance.
    Mangrum A; Bakris GL
    J Diabetes Complications; 1997; 11(6):352-7. PubMed ID: 9365878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
    McKenna K; Thompson C
    Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes.
    Naidoo DP
    Cardiovasc J S Afr; 2002; 13(4):194-9. PubMed ID: 12389063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug treatment for hypertensive patients in special situations: diabetes and hypertension.
    Mogensen CE
    Clin Exp Hypertens; 1999; 21(5-6):895-906. PubMed ID: 10423111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.
    Mogensen CE
    J Intern Med; 2003 Jul; 254(1):45-66. PubMed ID: 12823642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature.
    Dinneen SF; Gerstein HC
    Arch Intern Med; 1997 Jul; 157(13):1413-8. PubMed ID: 9224218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microalbuminuria: prognostic implications.
    Bakris GL
    Curr Opin Nephrol Hypertens; 1996 May; 5(3):219-23. PubMed ID: 8737856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microalbuminuria in essential hypertension.
    Crippa G
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S74-7. PubMed ID: 11986900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM; Palmer BF; Ram CV
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is antihypertensive treatment the same for NIDDM and IDDM patients?
    Parving HH
    Diabetes Res Clin Pract; 1998 Apr; 39 Suppl():S43-7. PubMed ID: 9649959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria.
    Nosadini R; Solini A; Velussi M; Muollo B; Frigato F; Sambataro M; Cipollina MR; De Riva F; Brocco E; Crepaldi G
    Diabetes; 1994 Mar; 43(3):491-9. PubMed ID: 8314023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
    Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure control, microalbuminuria and cardiovascular risk in Type 2 diabetes mellitus.
    Marshall SM
    Diabet Med; 1999 May; 16(5):358-72. PubMed ID: 10342335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.
    Goa KL; Haria M; Wilde MI
    Drugs; 1997 Jun; 53(6):1081-105. PubMed ID: 9179532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers.
    Nosadini R; Tonolo G
    J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microalbuminuria in non-insulin-dependent diabetes mellitus. Implications for renal survival.
    Abbott KC; Sanders LR; Bakris GL
    Arch Intern Med; 1994 Jan; 154(2):146-53. PubMed ID: 8285809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microalbuminuria and urinary albumin excretion: French guidelines].
    Halimi JM; Hadjadj S; Aboyans V; Allaert FA; Artigou JY; Beaufils M; Berrut G; Fauvel JP; Gin H; Nitenberg A; Renversez JC; Rusch E; Valensi P; Cordonnier D;
    Ann Biol Clin (Paris); 2008; 66(3):277-84. PubMed ID: 18558566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.